And next year, Retatrutide is expected to enter the market, and this will work on 3 receptor sites, GLP-1, GIP and glucagon
GLP-1 medications are approved for adults who have a body mass index (BMI) of 30 or higher, or a BMI of at least 27 plus a weight-related medical condition, such as the following: Type 2 diabetes High blood pressure High cholesterol Obstructive sleep apnea Cardiovascular disease that increases the risk of heart attack or stroke MASH, or metabolic dysfunctionassociated steatohepatitis, a form of liver inflammation Avlin Imaeda, MD, PhD, a Yale Medicine gastroenterologist who is board-certified in obesity medicine, notes that qualifying for the medication based on heart disease aloneoften necessary for insurance coveragecan be challenging
One consideration worth noting: glycine may interact with certain medications, particularly clozapine and some diabetes medications
Weight Regain After Discontinuation Is the Rule, Not the Exception Without addressing: Insulin sensitivity Muscle preservation Nutrient status Lifestyle structure Most patients experience partial or full weight regain after stopping GLP-1 therapy
What Can Happen After the First Month The starter month may be priced differently from refills or dose-adjustment months
Salt, soft texture, warmth, and small portions can be your friends here
